Home
>
National Drug Code (NDC)
>
Piperacillin and Tazobactam
Piperacillin and Tazobactam - 0409-3385-13 - (Piperacillin and Tazobactam)
Drug Information of Piperacillin and Tazobactam
| Product NDC: | 0409-3385 |
| Proprietary Name: | Piperacillin and Tazobactam |
| Non Proprietary Name: | Piperacillin and Tazobactam |
| Active Ingredient(s): | 3; .375 g/15mL; g/15mL & nbsp; Piperacillin and Tazobactam |
| Administration Route(s): | INTRAVENOUS; PARENTERAL |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Piperacillin and Tazobactam
| Product NDC: | 0409-3385 |
| Labeler Name: | Hospira, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065362 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101021 |
Package Information of Piperacillin and Tazobactam
| Package NDC: | 0409-3385-13 |
| Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0409-3385-13) > 15 mL in 1 VIAL, SINGLE-USE |
NDC Information of Piperacillin and Tazobactam
| NDC Code | 0409-3385-13 |
| Proprietary Name | Piperacillin and Tazobactam |
| Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0409-3385-13) > 15 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0409-3385 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Piperacillin and Tazobactam |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS; PARENTERAL |
| Start Marketing Date | 20101021 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc |
| Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
| Strength Number | 3; .375 |
| Strength Unit | g/15mL; g/15mL |
| Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |
